Report: Gene Silencing Dashboard: Series Two TOC

Executive Summary
Key Findings and Implications
Gene Silencing Dashboard
Gene Silencing Market Opportunity Matrix
Survey Methodology
Survey Invitation Text
Respondent Demographics
Frequency of Performance of Life Science Techniques
Frequency of Performance of Gene Silencing Techniques
Reaction Throughput and Market Segment Growth Rates
Respondent' s Stated Price per Reaction
Total Market Size, Market Segment Sizes and Total Market Growth Rate
Market Shares by Segment (Share of Mention)
Customer Satisfaction and Interest In Switching Suppliers
Product Features That Influence Purchasing Decisions
Primary Downstream Applications
Desired Changes to Gene Silencing Products
Survey Questionnaire

Figures and Tables

Figure 1: Respondent' s Place of Employment
Figure 2: Respondent' s Country/Region
Figure 3: Respondent' s Job Title
Figure 4A: Respondent' s Areas of Expertise/Specialization
Figure 4B: Respondent' s Areas of Expertise/Specialization (Molecular Biology Excluded)
Figure 5: Number of Employees in Respondent' s Laboratories
Figure 6: Percentage of Respondents Performing Various Life Science Techniques at Least a Few Times per Year
Figure 7: Percentage of Respondents Performing RNAi/siRNA Experiments
Figure 8: Percentage of Respondents Performing Various Gene Silencing Techniques at Least a Few Times per Year
Figure 9: Percentage of Respondents That Perform RNAi Screens Using siRNA Libraries
Figure 10: Percentage of Respondents That Induce siRNAs in vivo from a Plasmid or Other Vector in Cells
Figure 11: Percentage of Respondents That Digest Long dsRNA in vivo using Dicer or other Enzymes
Figure 12: Percentage of Respondents that Express siRNA in vitro for Delivery into Cells
Figure 13: Percentage of Respondents that Use PCR Mediated siRNA Expression Cassettes to Generate siRNAs
Figure 14: Percentage of Respondents that Deliver Synthetic siRNAs into Cells (Instrument Mediated)
Figure 15: Percentage of Respondents that Deliver Synthetic siRNAs into Cells (Lipid Mediated)
Figure 16: Percentage of Respondents that Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Instrument Mediated)
Figure 17: Percentage of Respondents that Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Lipid Mediated)
Figure 18: Percentage of Respondents that Deliver Viral Vectors into Cells for Vector Based Gene Knockdown
Figure 19: Percentage of Respondents that Use a Reporter Systems to Track Gene Knockdown
Figure 20: Respondent' s Primary Supplier of Products for Performing RNAi Screens Using siRNA Libraries
Figure 21: Respondent' s Primary Supplier of Products to Induce siRNAs in vivo from a Plasmid or Other Vector in Cells
Figure 22: Respondent' s Primary Supplier of Products to Digest Long dsRNA in vivo using Dicer or Other Enzymes
Figure 23: Respondent' s Primary Supplier of Products to Express siRNA in vitro for Delivery into Cells
Figure 24: Respondent' s Primary Supplier of PCR Mediated siRNA Expression Cassettes to Generate siRNAs
Figure 25: Respondent' s Primary Supplier of Products to Deliver Synthetic siRNAs into Cells (Instrument Mediated)
Figure 26: Respondent' s Primary Supplier of Products to Deliver Synthetic siRNAs into Cells (Lipid Mediated)
Figure 27: Respondent' s Primary Supplier of Products to Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Instrument Mediated)
Figure 28: Respondent' s Primary Supplier of Products to Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Lipid Mediated)
Figure 29: Respondent' s Primary Supplier of Products for Viral Delivery of Vectors into Cells for Vector Based Gene Knockdown
Figure 30: Respondent' s Primary Supplier of Reporter Systems to Track Gene Knockdown
Figure 31: Percentage of Respondents That Have Switched Suppliers in the Last Six Months
Figure 32: Most Important Features of Products for Gene Silencing Experiments
Figure 33: Respondent' s Primary Downstream Application for RNAi Screens Using siRNA Libraries
Figure 34: Respondent' s Primary Downstream Application for Products to Induce siRNAs in vivo from a Plasmid or Other Vector in Cells
Figure 35: Respondent' s Primary Downstream Application for Products to Digest Long dsRNA in vivo using Dicer or Other Enzymes (Instrument Mediated)
Figure 15: Percentage of Respondents that Deliver Synthetic siRNAs into Cells (Lipid Mediated)
Figure 16: Percentage of Respondents that Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Instrument Mediated)
Figure 17: Percentage of Respondents that Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Lipid Mediated)
Figure 18: Percentage of Respondents that Deliver Viral Vectors into Cells for Vector Based Gene Knockdown
Figure 19: Percentage of Respondents that Use a Reporter Systems to Track Gene Knockdown
Figure 20: Respondent' s Primary Supplier of Products for Performing RNAi Screens Using siRNA Libraries
Figure 21: Respondent' s Primary Supplier of Products to Induce siRNAs in vivo from a Plasmid or Other Vector in Cells
Figure 22: Respondent' s Primary Supplier of Products to Digest Long dsRNA in vivo using Dicer or Other Enzymes
Figure 23: Respondent' s Primary Supplier of Products to Express siRNA in vitro for Delivery into Cells
Figure 24: Respondent' s Primary Supplier of PCR Mediated siRNA Expression Cassettes to Generate siRNAs
Figure 25: Respondent' s Primary Supplier of Products to Deliver Synthetic siRNAs into Cells (Instrument Mediated)
Figure 26: Respondent' s Primary Supplier of Products to Deliver Synthetic siRNAs into Cells (Lipid Mediated)
Figure 27: Respondent' s Primary Supplier of Products to Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Instrument Mediated)
Figure 28: Respondent' s Primary Supplier of Products to Deliver Plasmids into Cells for Plasmid Based Gene Knockdown (Lipid Mediated)
Figure 29: Respondent' s Primary Supplier of Products for Viral Delivery of Vectors into Cells for Vector Based Gene Knockdown
Figure 30: Respondent' s Primary Supplier of Reporter Systems to Track Gene Knockdown
Figure 31: Percentage of Respondents That Have Switched Suppliers in the Last Six Months
Figure 32: Most Important Features of Products for Gene Silencing Experiments
Figure 33: Respondent' s Primary Downstream Application for RNAi Screens Using siRNA Libraries
Figure 34: Respondent' s Primary Downstream Application for Products to Induce siRNAs in vivo from a Plasmid or Other Vector in Cells
Figure 35: Respondent' s Primary Downstream Application for Products to Digest Long dsRNA in vivo using Dicer or Other Enzymes

Gene Silencing Dashboard: Series Two

Table of Contents

Figures and Tables